# Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

> **NCT00152126** · NA · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 26 (actual)

## Conditions studied

- Neuroblastoma
- Central Nervous System Tumors
- Lymphomas
- Wilms Tumor

## Interventions

- **PROCEDURE:** Stem Cell Transplantation
- **DRUG:** Busulfan, Melphalan

## Key facts

- **NCT ID:** NCT00152126
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2005-08
- **Final completion:** 2009-02
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2009-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152126, "Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00152126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*